Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Aminopterin is a synthetic folic acid (Item No. 20515) derivative whose metabolite is a competitive inhibitor of dihydrofolate reductase, which is a cofactor for nucleic acid synthesis. Aminopterin has anticancer and immunosuppressive properties. Formulations containing it have been used for pediatric leukemia though methotrexate (Item No. 13960) is now more commonly used due to a more favorable therapeutic index.1,2,3 Aminopterin is a component of the widely used HAT (hypoxanthine-aminopterin-thymidine) medium to select cells for mammalian cell culture.4
WARNING This product is not for human or veterinary use.
1. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-
2. A quantitative comparison of the antileukemic effectiveness of two folic acid antagonists in mice. J. Natl. Cancer Inst. 15(6), 1657-1664 (1955).
3. Phase II trial of oral aminopterin for adults and children with refractory acute leukemia. Clin. Cancer Res. 11(22), 8089-8096 (2005).
4. Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants. Science 145(3633), 709-710 (1964).